Miraca Life Sciences expands therapeutic drug monitoring service includes Simponi: 4 key notes

Irving, Texas-based Miraca Life Sciences expanded its InformTx therapeutic drug monitoring program to include Simponi and patient-developed antibodies to Simponi.

Advertisement

Here’s what you should know.

1. Miraca also performs monitoring for six biologic drugs used in inflammatory bowel disease treatments.

2. Simponi manages inflammatory bowel disease.

3. Miraca is the only therapeutic drug monitoring testing service for IBD patients.

4. InformTx reports include quantitative test results, historical test result data and advisory guidance based on peer-reviewed scientific literature.

More articles on gastroenterology:
Scientists on brink of identifying irritable bowel syndrome’s cause: 4 study insights
Replaced Olympus duodenoscopes tied to new bacterial outbreak in overseas facility: 6 key notes
Colorectal cancer rates rocketing in millennials — 5 study insights

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.